Laura Fontana
AOL (United States)(US)University of Milan(IT)Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico(IT)Ospedale Maggiore(IT)University Hospital of Zurich(CH)Ospedale San Paolo(IT)Azienda Socio Sanitaria Territoriale Santi Paolo e Carlo
Publications by Year
Research Areas
Genetic Syndromes and Imprinting, MicroRNA in disease regulation, Epigenetics and DNA Methylation, Prenatal Screening and Diagnostics, Genomic variations and chromosomal abnormalities
Most-Cited Works
- → MicroRNAs 221 and 222 inhibit normal erythropoiesis and erythroleukemic cell growth via kit receptor down-modulation(2005)762 cited
- → MicroRNAs 17-5p–20a–106a control monocytopoiesis through AML1 targeting and M-CSF receptor upregulation(2007)447 cited
- → Antagomir-17-5p Abolishes the Growth of Therapy-Resistant Neuroblastoma through p21 and BIM(2008)384 cited
- → miR181b is induced by the chemopreventive polyphenol curcumin and inhibits breast cancer metastasis via down‐regulation of the inflammatory cytokines CXCL1 and ‐2(2014)178 cited
- → Genetics of Mayer–Rokitansky–Küster–Hauser (MRKH) syndrome(2016)178 cited
- → Fibronectin is required for integrin o:vβ6‐mediated activation of latent TGF‐β complexes containing LTBP‐1(2005)172 cited